Delivery Order SPE2DB20D1100-SPE2DB25FB2Q8

Award Date 3/20/25
Potential Completion Date 3/21/25
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DIGIFAB 40 MG VIALS, a medical product, with a ceiling value of $8,748.03. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of November 8, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $15,064.55 to Amerisourcebergen Drug Corp, a for-profit organization, for the supply of DIGIFAB 40 MG VIALS. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver pharmaceutical products...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $49,743.59, is a Delivery Order for "DIGIFAB 40 MG VIALS" and has a firm fixed price. The contract has an ultimate completion date of April 10, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,738,224 units of the pharmaceutical product DIGIFAB 40 MG VIALS. The contract has a potential value of $37,013.12 and a completion date of February 23, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,708.88 firm-fixed-price delivery order is for 4560539206 DIGIFAB 40 MG VIALS, with an ultimate completion date of April 11, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,044.15 firm fixed-price delivery order is for the supply of DIGIFAB 40 MG VIALS, a medical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $68,837.73, is for the delivery of DIGIFAB 40 MG VIALS, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a period of performance ending on February 14, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of pharmaceutical product "DIGIFAB 40 MG VIALS" to the Defense Logistics Agency (DLA). The Firm Fixed Price contract is valued at $23,328.08 and has a period of performance through May 24, 2024. The contract is not set aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide DIGIFAB 40 MG VIALS. The firm fixed price contract has a potential value of $5,832.02 and a completion date of January 4, 2024. The contract is not associated with a set-aside program. Amerisourcebergen Drug Corp, as a prime contractor, has provided a range of pharmaceutical products and medical supplies to support DLA Troop Support...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution services company. The $61,547.51 contract is for the provision of DIGIFAB DIGOXIN 1S, a pharmaceutical product, with a completion date of March 22, 2024. The award does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FB2Q8
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,561.45, is for the procurement of DIGIFAB 40 MG VIALS, a medical product. The contract is a Firm Fixed Price (FFP) Delivery Order with a period of performance through March 2025. This contract is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 6/19/25, 9:49 AM